Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients - Giusti, B; Gori, AM; Marcucci, R (Pharmacogenet Genomics, 2007)
et al.